Clinical Trial Update: A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating RC88 in combination with Sintilimab for advanced solid tumors, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• RC88
• Sintilimab (sintilimab)

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Advanced Solid Tumours | Phase 1, Phase 2 | Status: RECRUITING